FAAN

The Aging Revolution: Growing old in America becoming more dignified, but with senior population booming, is nation’s health system prepared?

Retrieved on: 
火曜日, 6月 4, 2024

The apathy often resulted in inferior care for aging adults who frequently struggled with multiple chronic conditions that were largely ignored by physicians, who saw pain and suffering as inevitable to the aging process.

Key Points: 
  • The apathy often resulted in inferior care for aging adults who frequently struggled with multiple chronic conditions that were largely ignored by physicians, who saw pain and suffering as inevitable to the aging process.
  • The book, published by Skyhorse Publishing , analyzes the social action movements since the 1970s that have dramatically improved the quality of life and life expectancy of adults.
  • The emergence and expansion of palliative care programs to manage patients’ pain and improve quality of life, a specialized medical practice that has spread to nearly every US health system.
  • New initiatives that train, partially compensate and support millions of family caregivers tending to loved ones in the home.

Korro to Participate in Upcoming June Investor and Scientific Conferences

Retrieved on: 
木曜日, 5月 30, 2024

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences:

Key Points: 
  • CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences:
    Chief Executive Officer and President, Ram Aiyar, Ph.D., will present on Thursday, June 6, 2024, at 2:00 p.m.
  • Chief Financial Officer, Vineet Agarwal, will also be participating at the conference.
  • Dr. Krishnamurthy will also deliver a presentation titled “Edit the Message: Rewrite the Future” on June 20 at 1:30 p.m.
  • A live webcast of the Jefferies presentation can be accessed on the “Events & Presentations” page in the Investor section of Korro’s website at www.korrobio.com.

Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)

Retrieved on: 
火曜日, 5月 28, 2024

In recognizing the need for accessibility and inclusion in such programs for individuals with ALS, Clene instituted significant manufacturing, operational, and personnel efficiencies to expand the program’s accommodation to up to 180 participants.

Key Points: 
  • In recognizing the need for accessibility and inclusion in such programs for individuals with ALS, Clene instituted significant manufacturing, operational, and personnel efficiencies to expand the program’s accommodation to up to 180 participants.
  • “The Clene team recognized that there was great need in the ALS community for more access to promising treatments,” Austin Rynders, VP Clinical Operations at Clene, reflected on this effort.
  • “By leveraging our telehealth platform, Synapticure extends the reach of expanded access programs to people throughout the US.
  • With a nationwide presence, we enable people living with ALS access to investigational medicines like CNM-Au8 who have not previously had the option."

Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy

Retrieved on: 
火曜日, 5月 28, 2024

“The formation of this Clinical Advisory Board marks a major development step for Satellos as we continue our evolution in becoming a clinical stage drug development company,” said Frank Gleeson, Co-founder and CEO of Satellos.

Key Points: 
  • “The formation of this Clinical Advisory Board marks a major development step for Satellos as we continue our evolution in becoming a clinical stage drug development company,” said Frank Gleeson, Co-founder and CEO of Satellos.
  • Research in his laboratory focuses on utilizing genome editing technologies like CRISPR for the development of therapeutic approaches for neurogenetic disorders.
  • Francesco Muntoni, M.D., Director, Dubowitz Neuromuscular Centre, Great Ormond Street UCL Institute of Child Health, is focused on advancing novel therapeutics in translational and clinical research for pediatric neuromuscular disorders, especially Duchenne muscular dystrophy.
  • Dr. Shieh’s principal clinical interests include Duchenne muscular dystrophy (DMD), facioscapulohumeral muscular dystrophy (FSHD), and myotonic dystrophy.

NCSBN Issues Fraud Detection Guidance for Employers and Educators

Retrieved on: 
木曜日, 5月 23, 2024

Chicago, May 23, 2024 (GLOBE NEWSWIRE) -- NCSBN has developed a statement, “ Fraud Detection Guidance for Employers and Educators ,” to provide direction for nursing education programs, employers and others who assess nursing applicants for advanced study, employment, certification and other uses.

Key Points: 
  • Chicago, May 23, 2024 (GLOBE NEWSWIRE) -- NCSBN has developed a statement, “ Fraud Detection Guidance for Employers and Educators ,” to provide direction for nursing education programs, employers and others who assess nursing applicants for advanced study, employment, certification and other uses.
  • Cognizant that fraud is pervasive across all segments of society but especially dangerous within the health care sector, NCSBN has published recommendations to help prevent fraudulent individuals from entering nursing programs and health care organizations.
  • Fraud in nursing is a serious health concern posing a threat to patients and eroding their confidence in the profession.
  • This statement is designed to increase awareness and help implement methods of fraud detection and prevention,” comments NCSBN Director of Nursing Education Nancy Spector, PhD, RN, FAAN, one of the statement’s authors.

Frontier Nursing University and Campion Fund to Host Maternal Mortality Conference

Retrieved on: 
水曜日, 5月 22, 2024

Versailles, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- Frontier Nursing University (FNU) and the Campion Fund announced plans for a conference focused on the nation’s maternal mortality crisis.

Key Points: 
  • Versailles, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- Frontier Nursing University (FNU) and the Campion Fund announced plans for a conference focused on the nation’s maternal mortality crisis.
  • “Reducing Maternal Mortality: Strategies That Work!” will be held on Thursday, September 19, on the FNU campus in Versailles, Kentucky.
  • This research-oriented conference focuses on identifying and describing programs and practices that successfully reduce maternal mortality rates, essential for improving maternal health in the United States.
  • “This conference aims to identify and describe programs and practices that have successfully reduced maternal mortality rates.”
    Maternal mortality rates are alarmingly high for all women, with non-Hispanic Black women experiencing maternal mortality at more than 2.5 times the rate of white women.

Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

Retrieved on: 
金曜日, 5月 17, 2024

SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at 12:00 PM ET.

Key Points: 
  • SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at 12:00 PM ET.
  • The discussion will address the unmet medical need in Traumatic Brain Injury (TBI), commonly known as concussion, explore common causes, and examine its association with other long-term neurological disorders.
  • Additionally, the company will present its lead drug candidate, ONP-002, an innovative neurosteroid designed to treat mild TBI and discuss its outcomes from preclinical and Phase I trials, as well as details of an upcoming Phase II clinical trial to be conducted in acute and emergency departments.
  • Details for the webinar are as follows:
    James P. Kelly, MA, MD, FAAN, FANA, Emeritus Professor of Neurology and PM&R, University of Colorado School of Medicine
    Frank Peacock, IV, MD, FACEP, FACC, FESC, Vice Chair for Emergency Medicine Research, Baylor College of Medicine

HD Nursing Advocates for Women’s Health and Safety During National Women’s Health Week

Retrieved on: 
水曜日, 5月 15, 2024

During National Women’s Health Week (NWHW) May 12-18, HD Nursing , the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention, reaffirms its commitment to advancing women's health and safety, particularly during pregnancy and postpartum recovery.

Key Points: 
  • During National Women’s Health Week (NWHW) May 12-18, HD Nursing , the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention, reaffirms its commitment to advancing women's health and safety, particularly during pregnancy and postpartum recovery.
  • An estimated 1 in 4 women experiences a fall during pregnancy, posing serious risks to both mother and baby.
  • This points to the value of HD Nursing’s Maternal HDS©, meticulously mapped to evidence-based interventions aimed at minimizing fall risks for expectant and postpartum mothers.
  • Linked to targeted interventions, this tool plays a vital role in reducing fall risk and promoting safety in the maternal population.”

Joyce University Provost Appointed to the NLN Foundation Advisory Council

Retrieved on: 
木曜日, 5月 9, 2024

Joyce University is pleased to announce the appointment of Provost and Chief Academic Officer Dr. Lynn Bilder, PhD, APRN, WHNP-BC, to the prestigious Advisory Council for the NLN Foundation for Nursing Education .

Key Points: 
  • Joyce University is pleased to announce the appointment of Provost and Chief Academic Officer Dr. Lynn Bilder, PhD, APRN, WHNP-BC, to the prestigious Advisory Council for the NLN Foundation for Nursing Education .
  • View the full release here: https://www.businesswire.com/news/home/20240509976008/en/
    Dr. Bilder brings a wealth of experience to the NLN Foundation, a leading advocate for nursing faculty and leaders in nursing education.
  • At Joyce University, she works with deans, department chairs, faculty, and others on campus to support excellence in all of the university's academic, research, scholarly programs, and activities.
  • “We are thrilled to welcome Dr. Bilder to the NLN Foundation Advisory Council,” said NLN Foundation Chair Patrick Robinson, PhD, RN, ACRN, CNE, ANEF, FAAN, vice president of nursing, Pacific College of Health and Science.

AORN CEO to Retire

Retrieved on: 
木曜日, 5月 9, 2024

DENVER, May 9, 2024 /PRNewswire/ -- Linda K. Groah, MSN, RN, CNOR, NEA-BC, FAAN, the CEO and Executive Director of AORN (Association of periOperative Registered Nurses), has announced her plans to retire at the end of this year after a new CEO is selected.

Key Points: 
  • DENVER, May 9, 2024 /PRNewswire/ -- Linda K. Groah, MSN, RN, CNOR, NEA-BC, FAAN, the CEO and Executive Director of AORN (Association of periOperative Registered Nurses), has announced her plans to retire at the end of this year after a new CEO is selected.
  • She had also served as AORN Board President for the 1996-1997 term.
  • As CEO, Groah has had a key role in advancing changes to improve perioperative nursing practice and furthering AORN's mission supporting patient and workplace safety.
  • But Linda modeled resilience for staff and steered us to embrace greater collaboration and innovation," said AORN CFO James Cousin.